Workshop Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences WORKSHOP PROGRAMME 4-5 May 2009 OECD Headquarters 2, Rue Andre-Pascal, 75016 Paris For further information, please contact: Ms. Christina Sampogna. Tel: + 33 (0) 1 45 24 98 21; Fax: + 33 (0) 1 44 30 63 36; Email: Christina.sampogna@oecd.org
PROGRAMME WORKSHOP ON COLLABORATIVE MECHANISMS FOR INTELLECTUAL PROPERTY MANAGEMENT IN THE LIFE SCIENCES 9:30 10:30 KEYNOTE ADDRESS Monday, May 4, 2009 Pier Carlo PADOAN, Deputy Secretary General, OECD INTRODUCTION: CHALLENGES AHEAD - FOSTERING INNOVATION AND R&D This session will describe current and upcoming challenges for governments, industry, universities, research organisations, patient groups, technology transfer offices, and the global community in view of fostering R&D and stimulating innovation as well as set out the workshop objectives. OECD Secretariat 11:00 11:30 COFFEE BREAK 10:30-12:30 SESSION 1: INTELLECTUAL PROPERTY SHARING: MODEL AGREEMENTS & FRAMEWORKS Chair: Margaret MCKAY, Lead, IP Policy and IP Management Guidelines Project, National Research Council of Canada University Collaboration: Innovative Frameworks for Networking Jeanne JORDANOV, President, GRAVIT Collaborative Frameworks: Public Sector - Angus LIVINGSTONE, Managing Director, University-Industry Liaison Office, University of British Columbia - Matthew HERDER, Visiting Professor of Law, University of Chicago NIH Model Agreements Mark ROHRBAUGH, Director, Office of Technology Transfer, United States National Institutes of Health Lambert Model Collaborative Research Agreement Malcolm SKINGLE, Director of External Science & Technology, GlaxoSmithKline
12:30 14:00 LUNCH 14:00-15:45 SESSION 2: COLLABORATIVE INNOVATION Chair: Samuel ABRAHAM, Vice President, Strategic Relationships, British Columbia Cancer Agency Creative Life Science Success John A. THOMSON, Senior Vice President, Strategic Research Alliances, Vertex Pharmaceuticals Inc. Collaboration in Synthetic Biology Andrew TORRENCE, Professor, School of Law, University of Kansas Creative Collaboration Across Industry & Academia Hans SCHUITMAKER, Programme Manager, TI Pharma Creative Collaboration Ilan PELED, Director, MAGNET 15:45 16:15 COFFEE BREAK 16:15-18:00 SESSION 3: CLEARINGHOUSES, EXCHANGES/AUCTIONS, BROKERAGES Chair: Richard JOHNSON, Senior Partner, Arnold & Porter Exchange of Technology Through Open Clearinghouses Keith BERGELT, CEO, Open Invention Network Clearinghouse for Environmental Technologies: Eco-Patent Commons Nicolas GROLLIER, Director, IBM Corporation Auctioning of Intellectual Property Rights Jonathan BARNEY, Managing Director, OceanTomo Brokering for Research: Animal Models Martin Hrabé de ANGELIS, Director, European Mouse Mutant Archive Challenges for Establishing Clearinghouses/Exchanges Jeffrey P. KUSHAN, Partner, Sidley Austin
Tuesday, May 5, 2009 9:00-9:30 KEYNOTE ADDRESS Ian FLETCHER, Chief Executive, United Kingdom Intellectual Property Office 9:30-13:00 SESSION 4: PATENT POOLING Chair: Richard JOHNSON, Senior Partner, Arnold & Porter Patent Pooling in Agriculture: Golden Rice Ingo POTRYKUS, Emeritus Professor, Swiss Federal Institute of Technology Patent Pooling for Research ips : Yutaka TERANISHI, Professor, Kyoto University, Innovation Centre Patent Pool for Medicines: David ROSENBERG, Vice President, GlaxoSmithKline Patent Pooling in ICT: MPEG LA William L. GEARY, Jr., Vice President, MPEG LA Patent Pooling & Standards: UHF RFID Jason Johnson, Vice President, RFID Consortium (tbc) Challenges in Establishing Patent Pools Richard JOHNSON, Senior Partner, Arnold & Porter Anti-Trust / Competition & Legal Issues Christine VARNEY, Assistant Attorney General, DOJ (tbc) 11:00 11:30 COFFEE BREAK 13:00 14:30 LUNCH
14:30-16:45 SESSION 5: POLICY ROUND TABLE DISCUSSION Chair: Ian FLETCHER, Chief Executive, United Kingdom Intellectual Property Office This session will be a Roundtable discussion involving government delegates, session chairs, speakers, and experts. Characteristics of promising approaches and good practices/lessons learned; Challenges identified and knowledge gaps; Workshop messages. Challenges for Government Action & Policy Making Discussion Leader: Jim HOULIHAN, Senior Policy Advisor, United Kingdom Intellectual Property Office/DUIS Lisa DROUILLARD, Director, Department of Industry Canada Challenges for the Public Sector Discussion Leaders: Margaret MCKAY, Lead, IP Policy and IP Management Guidelines Project, National Research Council of Canada Mark ROHRBAUGH, Director, Office of Technology Transfer, United States National Institutes of Health Challenges for R&D: Private Sector Perspective Discussion Leaders: Richard JOHNSON, Senior Partner, Arnold & Porter John A. THOMSON, Senior Vice President, Strategic Research Alliances, Vertex Pharmaceuticals Inc. 15:15 15:45 COFFEE BREAK 16:45-17:15 OECD SUMMARY & CLOSING REMARKS Iain GILLESPIE, Head, Science and Technology Policy Division